Retraction Note to: A stepwise-targeting strategy for the treatment of cerebral ischemic stroke

Affiliations

¹ Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, 315211, China. hujingbo@nbu.edu.cn.
² College of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, 315100, China.
³ Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, 315211, China.
⁴ State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agroproducts, Institute of Plant Virology, Ningbo University, Ningbo, 315211, Zhejiang, China. pengjiejun@nbu.edu.cn.
⁵ Department of Neurosurgery, The People's Hospital of Lishui, The Sixth Affliated Hospital of Wenzhou Medical University, Lishui, 323000, China.
⁶ Department of Pharmacy, Ningbo Women and Children's Hospital, Ningbo, 315012, China.
⁷ Department of Neurosurgery, The People's Hospital of Lishui, The Sixth Affliated Hospital of Wenzhou Medical University, Lishui, 323000, China. liujin-614@163.com.

^# Contributed equally.

Jingbo Hu et al. J Nanobiotechnology. 2022.

. 2022 Oct 12;20(1):443.

doi: 10.1186/s12951-022-01645-w.

¹ Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, 315211, China. hujingbo@nbu.edu.cn.
² College of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, 315100, China.
³ Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, 315211, China.
⁴ State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agroproducts, Institute of Plant Virology, Ningbo University, Ningbo, 315211, Zhejiang, China. pengjiejun@nbu.edu.cn.
⁵ Department of Neurosurgery, The People's Hospital of Lishui, The Sixth Affliated Hospital of Wenzhou Medical University, Lishui, 323000, China.
⁶ Department of Pharmacy, Ningbo Women and Children's Hospital, Ningbo, 315012, China.
⁷ Department of Neurosurgery, The People's Hospital of Lishui, The Sixth Affliated Hospital of Wenzhou Medical University, Lishui, 323000, China. liujin-614@163.com.

^# Contributed equally.

No abstract available

Retraction of

A stepwise-targeting strategy for the treatment of cerebral ischemic stroke.
Hu J, Tan X, Wang D, Li Y, Liang H, Peng J, Li F, Zhou Q, Geng P, Wang S, Yu Y, Liu J. Hu J, et al. J Nanobiotechnology. 2021 Nov 17;19(1):371. doi: 10.1186/s12951-021-01118-6. J Nanobiotechnology. 2021. Retraction in: J Nanobiotechnology. 2022 Oct 12;20(1):443. doi: 10.1186/s12951-022-01645-w. PMID: 34789285 Free PMC article. Retracted.

1. Hu J, Li Sh, Kang X, Qi J, Wu J, Wang X, Xu X, Ying X, Jiang S, You J, Du Y. CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohyd Polym. 2018;193:268–280. doi: 10.1016/j.carbpol.2018.04.011. - DOI - PubMed
1. Wang S, Tan X, Li S, Zhou Y, Geng P, Hua A, Deng A, Yu Z. Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance. Oncotarget. 2017;8(67):111281. doi: 10.18632/oncotarget.22781. - DOI - PMC - PubMed
1. Hu JB, Liu D, Qi J, Lu KJ, Jin FY, Ying XY, You J, Du YZ. An E-selectin targeting and MMP-2-responsive dextran–curcumin polymeric prodrug for targeted therapy of acute kidney injury. Biomater Sci. 2018;6(12):3397–3409. doi: 10.1039/C8BM00813B. - DOI - PubMed
1. Peng J, Yin Y, Liang H, Lu Y, Zheng H, Wu G, Rao S, Chen J, Yan F, Hu J. Tumor microenvironment responsive pepper mild mottle virus-based nanotubes for targeted delivery and controlled release of paclitaxel. Front Bioeng Biotechnol. 2021;9:763661. doi: 10.3389/fbioe.2021.763661. - DOI - PMC - PubMed